ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Global Stem Cell Manufacturing Market Research Report 2018 – Increased Market Focus on Embryonic Stem Cells … – PR Newswire (press release)

South China Morning PostGlobal Stem Cell Manufacturing Market Research Report 2018 – Increased Market Focus on Embryonic Stem Cells …PR Newswire (press release)The global stem cell manufacturing market is projected to reach USD 14.61 Billion by 2023 … Continue reading

2018-04-03 Michael Zand NEWS

Global Stem Cell Manufacturing Market Research Report 2018 – Increased Market Focus on Embryonic Stem Cells … – PR Newswire (press release)

South China Morning PostGlobal Stem Cell Manufacturing Market Research Report 2018 – Increased Market Focus on Embryonic Stem Cells …PR Newswire (press release)The global stem cell manufacturing market is projected to reach USD 14.61 Billion by 2023 … Continue reading

2018-04-03 Michael Zand NEWS

Researchers Map Tumor Suppressive Landscape of Lung Cancer in Mice Using CRISPR, Barcode Seq – GenomeWeb

Researchers Map Tumor Suppressive Landscape of Lung Cancer in Mice Using CRISPR, Barcode SeqGenomeWebNEW YORK (GenomeWeb) – Researchers at Stanford University and the Massachusetts Institute of Technology used a combination of tumor barcoding, CRISPR-… Continue reading

2018-04-03 Michael Zand NEWS

Stem Cell Manufacturing (HSCs, MSCs, iPSCs, ESCs, Instruments, Media, Consumables) Market – Global Forecast to … – Business Wire (press release)

Stem Cell Manufacturing (HSCs, MSCs, iPSCs, ESCs, Instruments, Media, Consumables) Market – Global Forecast to …Business Wire (press release)The growing public-private investments and funding in stem cell-based research, rising public awareness regar… Continue reading

2018-04-03 Michael Zand NEWS

Pfizer signs a deal with Allogene to develop a cancer cell therapy – CNBC

Continue reading

2018-04-03 Michael Zand NEWS

Oops! CRISPR Concerns Turn Out to be a Big Nothingburger – Motley Fool

Wall Street MorningOops! CRISPR Concerns Turn Out to be a Big NothingburgerMotley FoolYou might have thought last year that the curtains were closing on a promising gene-editing therapy called CRISPR-Cas9. An article in Nature Methods published in May … Continue reading

2018-04-03 Michael Zand NEWS

Chemotherapy Exposure and T-Cell Fuel Source Reduce Potential to Develop CAR-T Therapy – www.oncnursingnews.com/

www.oncnursingnews.com/Chemotherapy Exposure and T-Cell Fuel Source Reduce Potential to Develop CAR-T Therapywww.oncnursingnews.com/New research indicates that both a dependence on glycolysis and prior chemotherapy appear to reduce the potential for T … Continue reading

2018-04-03 Michael Zand NEWS

Scientists combine CRISPR and DNA barcoding to track cancer growth – Medical Xpress

Medical XpressScientists combine CRISPR and DNA barcoding to track cancer growthMedical XpressThe team achieved this result using CRISPR-Cas9 – a powerful gene-editing tool that can easily replace, modify, or delete genetic sequences inside organisms –… Continue reading

2018-04-03 Michael Zand NEWS
  • 1
  • …
  • 308
  • 309
  • 310
  • 311
  • 312
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

CNBC

Pfizer signs a deal with Allogene to develop a cancer cell therapy
CNBC
Pfizer said on Tuesday it signed an agreement with Allogene Therapeutics, a company formed by a consortium in which the drugmaker will hold a 25 percent stake, to further develop its allogenic CAR T cell therapy. The agreement will accelerate the …
Pfizer signs deal with Allogene to develop cancer cell therapyReuters
Kite founder’s new firm inks off-the-shelf CAR T deal with PfizerBioPharma-Reporter.com
Pfizer and Allogene Therapeutics Enter into Asset Contribution Agreement for Pfizer’s Allogeneic CAR T Immuno …Business Wire (press release)
Forbes –STAT
all 8 news articles »